Eric Hedrick, Chief Medical Officer at Epizyme, Inc. (EPZM), sold 2,000 shares at $28.67 ($57K) on 2014-09-15, disclosed to the SEC on 2014-09-15.
Scheduled sale ($57k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EPZM | SELL | 2014-07-17 | $63K | — | Filing → |
| EPZM | SELL | 2014-06-18 | $53K | — | Filing → |
| EPZM | SELL | 2014-02-12 | $395K | — | Filing → |